The Jynneos doses are immediately available.
Vaccine manufacturer Bavarian Nordic, which has locations in the U.S. and Europe, can offer 16.4 million more doses to the nation. Jynneos is the only FDA-approved monkeypox vaccine and is the CDC’s preferred option compared to the older-generation smallpox vaccine ACAM2000 manufactured by Emergent BioSolutions, according to CNBC.
While it likely won’t be considered a pandemic, the World Health Organization views the monkeypox outbreak as a “moderate” risk because of the clusters in non-endemic areas, according to a June 4 report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
